Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Lexaria Bioscience Corp LEXX

Alternate Symbol(s):  LEXXW

Healthcare
Lexaria Bioscience Corp. is a Canada-based biotechnology company. The Company is engaged in pursuing the enhancement of the bioavailability of a diverse and a range of active pharmaceutical ingredients (API) using DehydraTECH, its patented proprietary drug delivery technology. The Company’s patented drug delivery technology, DehydraTECH, is designed to improve the way active molecules enter the... see more

NDAQ:LEXX - Post Discussion

Lexaria Bioscience Corp > DehydraTECH-CBD relative to placebo
View:
Post by lscfa on Sep 07, 2021 9:10pm

DehydraTECH-CBD relative to placebo

Maybe ordinary CBD is just as effective against placebo too. Why no comparison of DehydraTECH CBD to regular CBD?
Comment by Yowza123 on Sep 07, 2021 9:33pm
Previous studies with Lexaria already showed DehydraTECH was vastly superior to CBD in other formats like this study  from earlier this year: https://ir.lexariabioscience.com/news-events/press-releases/detail/128/lexaria-issues-successful-results-from-first-2021-study "The study demonstrated that each of the new DehydraTECH 2.0 formulations delivered very high levels of CBD ...more  
Comment by WakeUPP on Sep 08, 2021 10:30am
dude WOW Previous study on 10 RATS!!!!!!!!!!!!! MOST study on rats have zero effetct on people READ!!!!!!!!!!!!! The market KNOWS
Comment by SkyLight8 on Sep 07, 2021 9:51pm
Only thing that matters is FDA approved as did $GWPH
Lexaria Bioscience Corp
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities